128 related articles for article (PubMed ID: 36344379)
1. [Adhesion of urologists to the recommendations of the French Urological Association Cancer Committee (CCAFU) in the imaging work-up of localized prostate cancer].
Trétarre B; Trouche-Sabatier SG; Foucan AS; Abdo N; Poinas G; Rébillard X; Azria D; Iborra F
Prog Urol; 2022 Dec; 32(16):1446-1454. PubMed ID: 36344379
[TBL] [Abstract][Full Text] [Related]
2. [RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].
Trouche-Sabatier SG; Rebillard X; Iborra F; Azria D; Daures JP; Poinas G; Abdo N; Delbos O; Gevorgyan A; Marchal S; Guillon R; Millet I; Lamy PJ; Lauche O; Reis-Borges R; Serre I; Topart D; Tretarre B;
Prog Urol; 2020 Dec; 30(16):1038-1044. PubMed ID: 33012630
[TBL] [Abstract][Full Text] [Related]
3. [CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers].
Soulié M; Coloby P; Irani J; Lebret T; Patard JJ; Pfister C; Richaud P; Rigaud J; Salomon L;
Prog Urol; 2013 Nov; 23 Suppl 2():S51-4. PubMed ID: 24485293
[TBL] [Abstract][Full Text] [Related]
4. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.
Amparore D; Campi R; Checcucci E; Sessa F; Pecoraro A; Minervini A; Fiori C; Ficarra V; Novara G; Serni S; Porpiglia F
Eur Urol Focus; 2020 Sep; 6(5):1032-1048. PubMed ID: 32553544
[TBL] [Abstract][Full Text] [Related]
5. [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
Neuzillet Y; Colin P; Comperat E; Dubosq F; Houede N; Larre S; Masson-Lecomte A; Pignot G; Puech P; Roumiguie M; Xylinas E; Mejean A; Roupret M
Prog Urol; 2016 Mar; 26(3):181-90. PubMed ID: 26777686
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].
Léon P; Cancel-Tassin G; Koutlidis N; Calves J; Funes de la Vega M; Fournier G; Valeri A; Cormier L; Larré S; Cussenot O
Prog Urol; 2017 Mar; 27(3):158-165. PubMed ID: 28258910
[TBL] [Abstract][Full Text] [Related]
7. [CCAFU evidence-based Clinical Practice Guidelines 2016-2018].
Prog Urol; 2016 Nov; 27 Suppl 1():S3-S23. PubMed ID: 27846933
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19].
Méjean A; Rouprêt M; Rozet F; Bensalah K; Murez T; Game X; Rebillard X; Mallet R; Faix A; Mongiat-Artus P; Fournier G; Neuzillet Y;
Prog Urol; 2020 Apr; 30(5):221-231. PubMed ID: 32224294
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists].
Colombel M; Davin JL; Filleul A; Rousseau C
Prog Urol; 2004 Apr; 14(2):182-8. PubMed ID: 15217132
[TBL] [Abstract][Full Text] [Related]
11. A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
Kato T; Tohi Y; Honda T; Matsuda I; Osaki Y; Naito H; Matsuoka Y; Okazoe H; Taoka R; Tsunemori H; Ueda N; Sugimoto M
Int J Urol; 2023 Mar; 30(3):289-297. PubMed ID: 36415128
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the French practices in brachytherapy using surveys].
Delattre B; Cormier L; Borgogno C; Descotes JL; Peiffert D; Hannoun-Levi JM; Moreau JL
Prog Urol; 2017 Oct; 27(12):626-631. PubMed ID: 28651992
[TBL] [Abstract][Full Text] [Related]
13. [Observational survey of the French Urological Association evaluating intermittent hormonal modalities treatment in prostate cancer in France].
Salomon L; Ploussard G; Coloby P; Kouri G; Lebret T; Méjean A; Prunet D; Soulié M
Prog Urol; 2014 May; 24(6):367-73. PubMed ID: 24821560
[TBL] [Abstract][Full Text] [Related]
14. [French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020].
Rozet F; Hennequin C; Beuzeboc P; Mathieu R; Mongiat-Artus P; Beauval JB; Cormier L; Fromont-Hankard G; Ploussard G; Renard-Penna R; Brureau L; Méjean A
Prog Urol; 2020; 30(8-9):430-438. PubMed ID: 32517891
[TBL] [Abstract][Full Text] [Related]
15. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
[TBL] [Abstract][Full Text] [Related]
16. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
17. [Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].
Gillitzer R; Hampel C; Thomas C; Schmidt F; Melchior SW; Pahernik S; Schmidberger H; Thüroff JW
Urologe A; 2009 Apr; 48(4):399-407. PubMed ID: 19352607
[TBL] [Abstract][Full Text] [Related]
18. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
19. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Ploussard G; Fiard G; Barret E; Brureau L; Créhange G; Dariane C; Fromont G; Gauthé M; Mathieu R; Renard-Penna R; Roubaud G; Rozet F; Ruffion A; Sargos P; Beauval JB; Rouprêt M
Prog Urol; 2022 Nov; 32(15):1275-1372. PubMed ID: 36400483
[TBL] [Abstract][Full Text] [Related]
20. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F; Marra G; Kasivisvanathan V; Grummet J; Nandurkar R; Ploussard G; Olivier J; Chiu PK; Valerio M; Gontero P; Guo H; Zhuang J; Barletta F; Leni R; Frydenberg M; Moon D; Hanegbi U; Landaumailto A; Snow R; Apfelbeck M; Kretschmer A; van den Bergh R; Novara G; Briganti A; Dal Moro F; Gandaglia G
J Urol; 2022 Oct; 208(4):830-837. PubMed ID: 36082555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
